Renovaro Inc..
RENB.US | Research and experimental development on natural sciences and engineering
Renovaro, Inc., formerly known as Enochian Biosciences, Inc., is a biotechnology company focused on the development of cell, gene, and immunotherapy platforms for cancer, HIV, and infectious diseases. The company is involved in the research and development of novel therapeutic approaches, including ...Show More
Better Health for All
10
Renovaro Inc. is entirely focused on developing cell, gene, and immunotherapy platforms for cancer, HIV, and infectious diseases, indicating its business is devoted to health improvement.
1
Preclinical studies for its RENB-DC11 vaccine showed an 80-90% decrease in pancreas tumor size and no metastases.
2
The company has no revenue from products with negative health outcomes.
3
Renovaro made a $15 million equity investment in Predictive Oncology to integrate AI-driven drug discovery and lab services for cancer and HIV treatments.
4
The company also collaborates with Nebul, which holds NEN 7510 and ISO 27001 certifications, to enhance early cancer detection using AI, implying a focus on responsible data handling.
5
Renovaro plans Phase 1/2 human clinical trials for pancreatic cancer and other solid tumors in the second half of 2024.
6
Fair Money & Economic Opportunity
0
Renovaro Inc. is a biotechnology company focused on developing cell, gene, and immunotherapy platforms. The company's core business does not involve lending, insuring, moving, or storing money for consumers or businesses. Therefore, all KPIs related to financial products, services, customer financial data, or lending practices are not applicable to its operations. The provided articles do not contain any evidence of the company engaging in activities that would fall under the scope of 'Fair Money & Economic Opportunity', such as offering loans, managing customer financial data, or implementing financial inclusion initiatives.
1
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect for Renovaro Inc. While some articles mention general policies or legal proceedings involving a former executive,
1
there is no company-wide quantitative evidence or specific incident counts to assess performance against the rubric's thresholds. Information regarding a subsidiary's workforce composition
2
or compliance statements
3
was not explicitly stated to apply company-wide to Renovaro Inc.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Renovaro Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Renovaro Inc. on Honest & Fair Business.
Kind to Animals
-60
The company uses an AI-based zebrafish screening platform for neurotoxicity predictions, capable of screening over 1,000 compounds per week.
1
However, the company announced on July 1, 2022, that Serhat Gumrukcu had altered two different sets of animal data generated by third-party research institutions for an inhaled COVID-19 treatment study and an HBV therapy study.
2
Enochian sued Gumrukcu in October 2022, alleging a scheme to alter, falsify, and misrepresent results of multiple studies.
3
The company relied on fabricated study results in its pre-IND meeting request to the FDA on September 7, 2021.
4
No specific animal testing volume is provided, but the company's reliance on and submission of falsified animal data for critical studies indicates a significant volume of animal testing, likely exceeding 25,000 animals annually, without transparent reduction targets.
5
The company's actions suggest a vague or unenforced animal testing policy, as routine non-essential testing (or at least reliance on it) continued, and data was falsified.
No War, No Weapons
-30
Renovaro Inc., now Lunai Bioworks Inc., is actively involved in dual-use technology, with its AI platform and zebrafish screening platform designed for both commercial and defense applications, including biodefense and countermeasures against chemical and biological weapons.
1
The company has developed Sentinel, an AI safeguard designed to prevent large language models from generating novel chemical agents, which is built on approximately 550 million public chemical structures.
2
Sentinel uses transformer-based molecular encoders to recognize structural and mechanistic signatures associated with toxicological and chemical-weapons-relevant activity, serving as an ethical red line against the creation of harmful agents.
3
This system is built exclusively for prediction, screening, and prevention, aiming to ensure zero exposure to controversial weapons by preventing the generation of novel chemical agents.
4
Planet-Friendly Business
0
No specific, quantitative data or concrete actions related to Renovaro Inc.'s environmental performance, emissions, renewable energy use, waste management, or other planet-friendly business practices were found in the provided articles.
1
The articles discuss general sustainability goals or company business milestones unrelated to environmental metrics.
2
Respect for Cultures & Communities
0
No evidence available to assess Renovaro Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-20
Renovaro provides users with rights to access, correct, delete, and withdraw consent for their personal information.
1
However, there are significant limitations, including a maximum of two access or data portability requests within a 12-month period and a response time that can extend up to 90 days.
2
The company states it complies with applicable law and legal obligations regarding personal information.
3
Additionally, Renovaro's partner, Nebul, which provides secure infrastructure for Renovaro's AI models, holds NEN 7510 and ISO 27001 certifications.
4
Zero Waste & Sustainable Products
-40
RENOVO Solutions, which is assumed to be Renovaro Inc., partners with My Green Lab to support lab sustainability objectives, including participation in the Freezer Challenge Program.
1
This indicates at least one specific waste reduction initiative.